2 Marijuana Penny Stocks to Watch

best marijuana penny stocks

Investing in penny stocks can often prove to be highly rewarding and if the stock in question belongs to a high growth sector then the chances of a significant return rise manifold. When a sector is still nascent then there is always a chance for smaller companies to grow.

penny pot stocks

That opens up an opportunity for those who want to invest in penny stocks. One such sector is the marijuana sector. It’s only a few years old and there are still plenty of small companies that have the potential to turn into large ones. Here is a look at two marijuana penny stocks one should track.

Marijuana Penny Stocks to Watch #2 OrganiGram Holdings

The first company to consider in this regard is OrganiGram Holdings Inc. (OGI), which has remained under the radar over the past months despite making some very impressive moves as a business. One of the more important factors in favor of OrganiGram is the fact that it is the only major marijuana grower in Eastern Canada.

marijuana penny stocks

That could give it the chance of dominating that market. It is interesting to note that despite the lower population, it has a higher percentage of marijuana consumers when compared to the Canadian national average.

Additionally, the company’s production capabilities are set to be enhanced. OrganiGram expects that it will be able to produce 100,000 kilos a year when at full capacity. The company claims that it’s going to yield 250 grams per square feet. This is significantly higher than the 75 grams per square feet that is being produced by most of its rivals. The legalization of edibles and other derivatives in Canada later on this year is another opportunity that could fuel the next stage of growth for OrganiGram.

5 Penny Stocks To Add To Your List In October

Marijuana Penny Stocks to Watch #2 MediPharm Labs

The other promising company in this respect is MediPharm Labs (LABS) (MEDIF), which has a lot of potentials and is involved in a very specialized space. The company is involved in processing and packaging hemp or marijuana extracts for other companies, which are then used for other purposes. MediPharm has become one of the leaders of that particular industry and has locked up some lucrative contracts with some of the leading marijuana producers.

It has inked a contract with plenty of producers, but its most significant contract is with Cronos Group. It has an 18-month deal in which it will supply Cronos with $30 million worth of concentrates and there is an option to double it to $60 million over a two year period as well. It started is extraction services only last November and has already become an industry leader.

Top Penny Stocks To Watch This Week

Investing in penny stocks can be risky. However, the bigger the risk the higher the reward, as they say. The goal is to buy penny stocks at the lowest price possible as to make a profit and sell as it goes up in value. Penny stocks are usually priced at $5 or less. So if you purchase a lot of said stock at a low price, it could go up in value. As a result, if you sell it you could potentially make money.

The Difference Between Penny Stocks and Blue Chip Stocks

Penny stocks are different than blue-chip stocks like Apple or Google.  If you think about penny stocks most are considered over the counter opposed to larger stocks trading on exchanges like Nasdaq or the New York Stock Exchange. It is crucial to research the companies you want to invest in because many could be hiding their financial information. If you can figure out the companies that are on the come up and have high earnings you could receive a high reward.

penny stocks to buy or sell 2019.jpg

But here is the beauty of penny stocks. Despite the risks, if you can stomach the volatility, you may have a shot at this wild west style market. Many penny stocks to watch will see monstrous breakouts; sometimes within the matter of a few hours. This having been said, let’s take a look at the following list of penny stocks to watch that are trading under $3 right now:

4 Penny Stocks To Buy For Less Than $3

What Are The Best Penny Stocks To Watch For September 23?

No one can predict the future. And in the penny stocks space, that couldn’t be truer. The fact of the matter is that penny stocks are incredibly volatile. The thought for most new investors is that these cheap stocks are lottery tickets and “if I make money, I’ll hit it big.”

That couldn’t be further from the truth. Penny stocks, just like any equity, carries its own risks. Also, as with most investments, there are plenty of methods to go about trading in order to have a better win rate.

To find the best penny stocks, you need to look at a few things. First, make sure there’s enough trading volume in the market. Next, you need to understand the dynamics of the market itself. Are penny stocks in a bear market?

top penny stocks.jpg

Which sectors are favoring a bullish market? And what are some of the hot penny stocks to watch on platforms like Twitter and Facebook? Having a clear-cut approach to trading is necessary especially if you really want to make money with penny stocks. Don’t treat it like a guessing game; treat it like an investment.

In the grand scheme of it, penny stocks are usually a small portion of a portfolio. But some day traders make a living off of only trading penny stocks. These traders are likely looking at the market like an investment opportunity and not a way to “win the lottery.” There are rules in place that also help these traders place winning trades more than losing ones.

But it takes a keen eye and plenty of experience in order to achieve that. So if you’re looking for some of the best penny stocks to watch, you should start looking in the right places.  One of the main platforms to do so this month has been on PennyStocks.com. Here are some of the site’s most read articles in September:

3 Penny Stocks To Buy In September?

Top 10 Penny Stocks On Robinhood To Watch For September

3 Penny Stocks On Robinhood To Watch This Week

Money Making Penny Stocks: One Is Up Over 21,000% This Quarter

3 Penny Stocks To Watch After September News

5 Penny Stocks To Buy For Under $1 In September

In many cases, these articles highlighted trending penny stocks to watch this month with many taking off to new highs. Obviously, we want to highlight good sources of information. The site itself doesn’t make recommendations to sell or buy penny stocks, but it does break down some of the key catalysts that could be taken into consideration.

How To Know Which Penny Stocks To Buy

penny stocks to buy

Even though there’s no magic trick to it, there are ways to figure out a list of penny stocks to watch; and possibly buy. These volatile, cheap stocks are plentiful and so are the big gains that come from some of them. One of the main things to understand is what drives penny stock prices. This can be boiled down into a few different categories:

How To Look At Penny Stocks

  1. Penny Stock News – Events broadcast by the company that signify a meaningful material event for a company that could set it up for success
  2. Penny Stock Disclosures – These are forms like 8-K, 13F, 4, and even 10K/Q. These will be the things that show important company information that is mandated by the SEC to report. They don’t need to be accompanied by a news release so sometimes you won’t see why a penny stock is moving until you look deeper into its filings.
  3. Industry News – Typically we see industry news trigger certain moves for penny stocks. These can be things like legalization when it comes to marijuana penny stocks or oil rig count when it comes to certain energy penny stocks. Other things like global economic news may impact other sectors. Needless to say, if a penny stock is moving and there aren’t any filings or company news, see what’s happening in the industry
  4. Technical Trading – This is the one that may not make sense to some. Technical levels or indicators for certain stocks may trigger a directional move. This is simply based on momentum and trend indicators from a chart. More times than not, a trader buying penny stocks on technicals alone may not even know any more about a company than its 2, 3, 4, or 5 -letter symbol.penny stocks to buy.jpg

No matter the case, it’s important to understand the risks that penny stock traders take.  Within the blink of an eye, you could hit the jackpot but the same holds true for losing it all.

That’s why it’s important to understand the basics of penny stocks and learn how to enact them in your trading strategy. For those who bought some of the penny stocks in this next article, they are likely up, handsomely. But can the trend continue or is it time to sell? You decide:

5 Penny Stocks To Buy For Under $1 In September

Can You Make Money With Penny Stocks? 3 To Watch For September

The question, “Can I make money with penny stocks,” isn’t new by any stretch of the imagination. The small cap and micro cap equities are defined as stocks trading below $5 a share. Though it does make sense that penny stocks would be defined as stocks trading for pennies, certain oversight of the space designated a price of $5 or less. In any event, penny stocks are incredibly risky but for those who’ve experienced the reward, you know that the risk is sometimes worth it.

penny stocks

With a new month upon us, penny stocks will be in focus. Many new college students will be looking for extra ways to make money. Because you can buy many shares of penny stocks, the niche is appealing especially for students.

However, it’s important to note that penny stocks and day trading small cap stock can require your full attention. This being said, make sure you know the basics of investing first. Then you’ll want to understand the penny stock basics as well. Keep in mind that learning how to invest isn’t an overnight thing. It can be a lifelong learning event for most successful traders.

3 Penny Stocks To Buy (or not) For September

4 Cannabis Stocks With Recent News

The legal cannabis market is predicted to hit USD $146.4 billion globally by 2025, according to a report by Grand View Research. This rapid growth is propelled by increased cannabis legalization seen around the globe as well as the growing use of cannabis in several medical applications.

marijuanastocks.jpg

As far as the stock market is concerned, legal recreational cannabis will account for as much as 61% of the industry overall, with the other 39% going to medicinal cannabis as well as the black market. Despite this, many cannabis stocks have been able to make quite a name for themselves given the massive amount of momentum and propensity toward future growth that the cannabis industry has shown over the last few years.

Leafbuyer Technologies, Inc. (LBUY)a leading cannabis technology and marketing platform, announced the launch of its innovative delivery technology to complement its mobile application. This week a preliminary beta launch will begin to include that dispensaries in states such as California, Arizona, Nevada, and Washington are now able to add delivery to their list of offerings through Leafbuyer’s Greenlight mobile app.

“The addition of this new technology will allow us to monetize our consumer base through a fee generated from each transaction,” said Kurt Rossner, CEO. “We’ll be able to penetrate thousands of new dispensaries and delivery companies in legal markets by offering this delivery solution. Leafbuyer will not physically deliver the products, rather we will hand off the ‘last mile’ to our delivery and dispensary partners.”

Leafbuyer reported that its quarterly cash sales growth increased 36% year over year in the quarter ending March 31, 2019, attributing its growth to platform enhancements. The platform allows consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at numerous participating dispensaries, and now delivery. The company recently launched a Los Angeles satellite office, which will become the primary regional office for several Western states, allowing sales initiatives to be more heavily focused on newly legal Midwestern and Eastern states.

Aphria Inc. (APHA), a Canadian cannabis company, announced it has closed its private placement offering of $300 million of 5.25% convertible senior notes due 2024 and that initial purchasers fully exercised their option to buy up to an additional $50 million of notes, resulting in gross proceeds of $350 million.  The company plans to use the net proceeds to support its international expansion initiatives, for future acquisitions as well as general corporate purposes.

This followed the news that its German subsidiary Aphria Deutschland GmbH has secured the previously announced license for the domestic cultivation of medical cannabis from the German Federal Institute for Drugs and Medical Devices and was granted a cultivation license for four of the nine total lots awarded.

“Aphria thanks the BfArM for their diligent examination and validation of our approach for domestic cultivation with this license,” said Hendrik Knopp, Managing Director of Aphria Germany. “Construction on our 8,000 square meter indoor cultivation facility is already underway and we anticipate it will be fully operational by Summer 2020. We are pleased to additionally support German patients in the upcoming months with high-quality imported cannabis flower and oils from Denmark and Canada.”

Aurora Cannabis Inc. (ACB), a world leading cannabis company, announced its contract with the German Federal Institute for Drugs and Medical Devices has been finalized allowing Aurora to begin construction on a new state of the art indoor cannabis production facility this May.

“We are thrilled with the positive outcome of the tender process, and excited to start construction on our latest production facility,” said Neil Belot, Chief Global BDO. “In addition to providing German medical patients with a local supply of high-quality, medical grade cannabis, this new facility will also bring additional new jobs to the German labour market. It’s a strong validation of our production and distribution standards to have been recognized as having the highest-rated overall concept out of 79 tender applications, and we look forward to continuing to increase availability of medical cannabis in this important market.”

This news followed the company entering a binding letter agreement with Hempco Food and Fiber Inc. (HEMP), a provider of hemp-based foods, fiber and nutraceuticals.  The agreement entails that Aurora will acquire all of the issued and outstanding common shares, not already owned, of Hempco at$1.04 per share in common shares of Aurora, for a valuation of C$63.4 million.

Canopy Growth Corporation (CGC) (WEED), a world-leading diversified cannabis and hemp company, announced last week it would acquire US cannabis company Acreage Holdings, Inc. (ACRGF) in a $3.4 billion cash and stock deal that will close if and when cannabis production and sales are legal at the federal level in the US.

“Today we announce a complex transaction with a simple objective,” Co-Chief Executive Bruce Linton said. “Our right to acquire Acreage secures our entrance strategy into the United States as soon as a federally permissible pathway exists. By combining Acreage’s management team, licenses and assets with Canopy Growth’s intellectual property and brands, there will be tremendous value creation for both companies’ shareholders.”

Following the news of this potential deal, a GMP Securities’ analyst upgraded Canopy Growth from Hold to Buy with a price target raised from $65 to $72.

marijuana.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam has been compensated an additional $100,000 by Leafbuyer Technologies for a period of coverage from April 12, 2019 to June 12, 2019. Midam owned 77,000 shares of Leafbuyer Technologies. Midammay buy or sell additional shares of (LBUY) in the open market at any time (as of 3/29/2019) Midam Ventures no longer owns 77,000 shares of (LBUY), including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.

4 Cannabis Stocks Heating Up The Markets

The cannabis sector gained one if its biggest votes of confidence to date when top Wall Street firm Bank of America -Merrill Lynch initiated coverage on four of the top cannabis stocks with mostly positive outlook for sector.  BofA is the latest of the Wall Street firms to add cannabis to their coverage, following the likes of Cowen, Jefferies and Piper Jaffray.

cannabisstocks.jpg

Cannabis stocks, for the most part, have started the year off on a strong foot with the Horizons’ Marijuana Life Sciences ETF (HMMJ) (HMLSF), the largest and most representative cannabis exchange traded fund, up about 45%.  As the cannabis sector continues to break new boundaries, investors seeking opportunities in the budding sector may benefit from keeping tabs on several cannabis stocks.

Leafbuyer Technologies, Inc. (LBUY), a leading cannabis technology and marketing platform that connects consumers to dispensaries and product companies, announced the establishment of the company’s first satellite office in Los Angeles, California. The new office is in addition to its original Denver Colorado headquarters and will become the primary regional office for several western states. This move will help Leafbuyer expand its national footprint by enabling sales initiatives to focus on newly legal Midwestern and Eastern states.

“California is now a mature recreational and medical cannabis market, which makes this the opportune time to establish a secondary operation in the southern part of this industry-leading state,” said Kurt Rossner, CEO.

Leafbuyer recently announced that its quarterly cash sales growth rose 36% year over year in the quarter ending March 31, 2019. The cannabis stock attributes this success to platform enhancements, order ahead and Leafbuyer loyalty as well as a multi-state sales team.  The platform allows consumers to order cannabis products ahead, earn loyalty points, and cut the line to pick up and pay at numerous participating dispensaries Leafbuyer plans to continue to expand its reach into newly legal US markets, while increasing consumer retention to boost bottom line revenues.

Canopy Growth Corporation (CGC) (WEED), a world-leading diversified cannabis and hemp company, is rumored to be preparing to purchase Acreage Holdings Inc, a U.S. cannabis company, by buying the right to purchase, according to Bloomberg and CNBC.  If Canopy Growth was to acquire the US-based cannabis company now, it would be delisted from the TSE since cannabis is illegal in the U.S., and the exchange does not allow companies to own stakes in businesses that run illegal operations.  Instead, Canopy Growth will purchase the rights to buy Acreage if or when cannabis becomes legal in the U.S. at an agreed-upon price, according to the source.

Bank of America (BAC) initiated new coverage Canopy Growth giving it a buy rating with a price target of $52.  On Tuesday, Co-CEO Bruce Linton updated the company’s revenue guidance at a cannabis conference in Toronto in which Canopy is anticipating at least $744 million in revenue in fiscal 2020, beating analyst estimates by 19 percent. The company also announced the completion of an all-cash acquisition of Spain-based licensed cannabis producer Cáñamo y Fibras Naturales, S.L. (Cafina). The acquisition paves the way for Canopy to expand its European production footprint.

“Operating multiple production assets within Europe will allow us to increase revenue in the EU free of supply constraints,” commented Mark Zekulin, President & Co-CEO. “This strategic acquisition in a scalable, low-cost production environment diversifies our owned production capabilities in Europe, similar to our approach in Canada where we have production facilities in seven different provinces. Adding Cafina will allow us to quickly build out our presence in Spain using its existing cultivation licence as a launch pad, while ensuring our Canadian footprint – the largest in the world – can continue to serve the medical and recreational needs of Canadians.”

HEXO Corp (HEXO), consumer packaged goods cannabis company, had Bank of America (BAC) initiated coverage on the stock giving it a buy rating and the title of its top cannabis stock pick.  Most recently, the company announced reaching a significant milestone of completing the first harvest in its 1 million sq. ft. expansion.

“Completing the first harvest in our 1,000,000 sq. ft. greenhouse expansion showcases the dedication and hard work of the entire HEXO team,” said Sébastien St-Louis, CEO and co-founder. “We are very proud of our continued ability to execute on our plans, creating value for our shareholders and demonstrating our commitment to our customers. This cultivation milestone means that an expanded HEXO product offering will be available to more Canadians shortly.”

In mid-March, HEXO announced a definitive arrangement agreement to acquire Newstrike Brands Ltd. (NWKRF) in a stock deal valued C$263 million ($196.7 million). This acquisition which will boost HEXO’s production capacity to 150,000 kg annually while increasing its domestic market access to 9 provinces.

Aurora Cannabis Inc. (ACB), a world leading cannabis company, also had Bank of America (BAC) initiate coverage on it stock giving it a buy rating and price target of $11. The company announced that, further to its April 5th press release, the public appeal process related to the German cannabis production tender has been completed, and Aurora’s contract with the German Federal Institute for Drugs and Medical Devices has been finalized allowing Aurora to begin construction on a new indoor cannabis production facility in May.

“We are thrilled with the positive outcome of the tender process, and excited to start construction on our latest production facility,” said Neil Belot, Chief Global Business Development Officer. “We are very proud of the work done by our European team.  In addition to providing German medical patients with a local supply of high-quality, medical grade cannabis, this new facility will also bring additional new jobs to the German labour market. It’s a strong validation of our production and distribution standards to have been recognized as having the highest-rated overall concept out of 79 tender applications, and we look forward to continuing to increase availability of medical cannabis in this important market.”

Also this week, Aurora announced entering a binding letter agreement with Hempco Food and Fiber Inc. (HEMP), a provider of hemp-based foods, fiber and nutraceuticals.  Per the agreement, Aurora will acquire all of the issued and outstanding common shares not already owned of Hempco and pay $1.04 per share in common shares of Aurora, for a valuation of C$63.4 million.

marijuanastocks.jpg


This blog is an affiliate of Midam Ventures, LLC. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to March 1, 2019. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to April 1, 2019. Midam has been compensated an additional $100,000 by Leafbuyer Technologies for a period of coverage from April 12, 2019 to June 12, 2019. Midam owned 77,000 shares of Leafbuyer Technologies. Midammay buy or sell additional shares of (LBUY) in the open market at any time (as of 3/29/2019) Midam Ventures no longer owns 77,000 shares of (LBUY), including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc. Click here for full Midam disclaimer.